ArticleJACC. Advances2025
Prediction of Aortic Stenosis Progression Using Artificial Intelligence: A Machine Learning Model.
Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Unimodal to multimodal: a systematic review of predictive machine learning models for valvular heart diseases.Frontiers in cardiovascular medicine · 2026Pooled it
- Article
- Contemporary Management of Aortic Stenosis: Timing of Intervention and Lifetime Valve Management.European journal of clinical investigation · 2026Review
- Categories of Aortic Stenosis: What's New and the Clinical Implications.Medicina (Kaunas, Lithuania) · 2026Review
- Clinical Applications of Artificial Intelligence in Structural Heart Disease.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent guidelines for monitoring aortic stenosis (AS) progression focus on serial echocardiographic assessment, which is resource-intensive and subject to variability. Artificial intelligence may offer an opportunity to enhance the early identification of patients at risk of developing severe AS.
objectivesThe objective of this study was to create an echo-based model that can predict whether a patient will deteriorate from mild/moderate AS to severe AS.
methodsWe retrospectively analyzed a single-center database of 529,751 echo exams and identified 9,330 echocardiograms of patients initially diagnosed with mild or moderate AS, 56% of which progressed to severe AS within 5 years. We developed a model agnostic to any patient data outside the scope of the echocardiography report, and the reports were obtained from a large database of a tertiary medical center. Performance was assessed for accuracy, area under the curve-receiver operating characteristic, and calibration SHapley Additive exPlanations values provided interpretability for the model's predictions.
resultsDuring the follow-up, 1,625 (47%) patients developed severe AS. The model demonstrated strong predictive performance-an area under the curve-receiver operating characteristic of 0.91, an accuracy of 83%, and an Integrated Calibration Index = 0.0576. The model successfully identified patients at high risk of progression, with robust calibration and generalizability confirmed through cross-validation.
conclusionsOur novel, echocardiography-focused artificial intelligence model is a reliable tool for the early identification of patients at risk of progression to severe AS. Pending future, multicenter, prospective validation, such models may facilitate personalized follow-up strategies and timely interventions, ultimately leading to improved patient outcomes and resource utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.